Wird geladen...
Neurological safety of fingolimod: An updated review
Fingolimod (FTY) is the first oral medication approved for treatment of relapsing–remitting multiple sclerosis (RRMS). Its effectiveness and safety were confirmed in several phase III clinical trials, but proper evaluation of safety in the real patient population requires long‐term post‐marketing mo...
Gespeichert in:
| Veröffentlicht in: | Clin Exp Neuroimmunol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5575715/ https://ncbi.nlm.nih.gov/pubmed/28932291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen3.12397 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|